Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Gross Margin (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Gross Margin data on record, last reported at 82.07% in Q4 2025.

  • For Q4 2025, Gross Margin fell 182.0% year-over-year to 82.07%; the TTM value through Dec 2025 reached 80.23%, down 33.0%, while the annual FY2025 figure was 80.23%, 33.0% down from the prior year.
  • Gross Margin reached 82.07% in Q4 2025 per INDV's latest filing, up from 73.25% in the prior quarter.
  • Across five years, Gross Margin topped out at 86.62% in Q1 2024 and bottomed at 73.25% in Q3 2025.